Core Insights - Awei Technology (688067) announced an investment of 10 million yuan in Hunan Luying Technology Co., Ltd., acquiring a 9.0744% stake in the company [2] Group 1: Investment Details - The investment is aimed at enhancing the synergy of Awei Technology's main business and improving its overall competitiveness [2] - The core business of Luying Technology involves the development of domestically produced high-resolution single-photon emission computed tomography (SPECT) and its core components [2] Group 2: Strategic Significance - Awei Technology believes that this investment aligns with its long-term development plan and has positive strategic implications for its operations [2]

Core Viewpoint - Awei Technology (688067.SH) plans to invest a total of RMB 30 million in Luying Technology, acquiring a 9.0744% stake through a capital increase [1] Group 1: Investment Details - The investment will be made in partnership with state-owned investment institutions, including Guangzhou Guangjin Life Health Industry Investment Fund and Hunan Xiangjiang New Area Guidance No. 1 Venture Capital Partnership [1] - Awei Technology will contribute RMB 10 million, which will allow it to subscribe to RMB 249.3766 million of the new registered capital of Luying Technology [1] - The capital increase agreement has been signed among the investment parties and existing shareholders of Luying Technology [1] Group 2: Company Profile - Luying Technology, registered in Changsha, Hunan Province, has a registered capital of RMB 20 million [1] - The company specializes in the development of domestically produced high-resolution single-photon emission computed tomography (SPECT) and its core components [1] - Luying Technology provides hospitals with precise, safe, economical, and convenient molecular imaging diagnostic solutions, focusing on high-end nuclear medicine imaging and treatment equipment [1]

Core Viewpoint - Awei Technology (688067.SH) plans to invest a total of RMB 30 million in Luying Technology, acquiring a 9.0744% stake through a capital increase [1] Group 1: Investment Details - The investment will be made in partnership with state-owned investment institutions, including Guangzhou Guangjin Life Health Industry Investment Fund and Hunan Xiangjiang New Area Guidance No. 1 Venture Capital Partnership [1] - Awei Technology will contribute RMB 10 million, which will allow it to subscribe for RMB 2.493766 million of the new registered capital of Luying Technology [1] - The capital increase agreement has been signed among the investment parties and existing shareholders of Luying Technology [1] Group 2: Company Profile - Luying Technology, registered in Changsha, Hunan Province, has a registered capital of RMB 20 million [1] - The company specializes in the development of domestically produced high-resolution single-photon emission computed tomography (SPECT) and its core components [1] - Luying Technology provides hospitals with precise, safe, economical, and convenient molecular imaging diagnostic solutions, focusing on high-end nuclear medicine imaging and treatment equipment [1]